<code id='94C55883C8'></code><style id='94C55883C8'></style>
    • <acronym id='94C55883C8'></acronym>
      <center id='94C55883C8'><center id='94C55883C8'><tfoot id='94C55883C8'></tfoot></center><abbr id='94C55883C8'><dir id='94C55883C8'><tfoot id='94C55883C8'></tfoot><noframes id='94C55883C8'>

    • <optgroup id='94C55883C8'><strike id='94C55883C8'><sup id='94C55883C8'></sup></strike><code id='94C55883C8'></code></optgroup>
        1. <b id='94C55883C8'><label id='94C55883C8'><select id='94C55883C8'><dt id='94C55883C8'><span id='94C55883C8'></span></dt></select></label></b><u id='94C55883C8'></u>
          <i id='94C55883C8'><strike id='94C55883C8'><tt id='94C55883C8'><pre id='94C55883C8'></pre></tt></strike></i>

          leisure time

          leisure time

          author:fashion    Page View:786
          Cosmetics
          Alberto Pellaschiar/AP

          WASHINGTON — For those already felled by fumes from the Brazilian Blowout, it might be small consolation, but lawmakers are pushing ahead with a campaign for better oversight of the beauty business.

          Despite its booming growth, the cosmetics industry in the US has been virtually unregulated. The Food, Drug, and Cosmetic Act, adopted in 1938, essentially allowed personal care product companies to self-police.

          advertisement

          But rising public concern over bad reactions to makeup, hair dyes, and fragrances, as well as evidence of long-term health risks from some of their chemical contents, has led lawmakers to try to toughen the regulatory framework for the $60 billion enhancement industry.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          Pharmacists can make shortage drugs, but at what cost?
          Pharmacists can make shortage drugs, but at what cost?

          AdobePharmacistsincreasinglyarebeingaskedtomakedrugsinbulkforhospitalsthatareinshortsupply,andthey’r

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Merck, Daiichi strike cancer drug pact worth up to $22 billion

          KenaBetancur/GettyImagesMADRID—MerckispayingbillionsofdollarstopartnerwithDaiichiSankyoonaseriesofca